150 related articles for article (PubMed ID: 8810922)
1. The role of electrostatic interactions in the assembly of the factor X activating complex on both activated platelets and negatively-charged phospholipid vesicles.
London F; Walsh PN
Biochemistry; 1996 Sep; 35(37):12146-54. PubMed ID: 8810922
[TBL] [Abstract][Full Text] [Related]
2. Annexin V inhibition of factor IXa-catalyzed factor X activation on human platelets and on negatively-charged phospholipid vesicles.
London F; Ahmad SS; Walsh PN
Biochemistry; 1996 Dec; 35(51):16886-97. PubMed ID: 8988028
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.
Panteleev MA; Saenko EL; Ananyeva NM; Ataullakhanov FI
Biochem J; 2004 Aug; 381(Pt 3):779-94. PubMed ID: 15104540
[TBL] [Abstract][Full Text] [Related]
4. The second epidermal growth factor-like domain of human factor IXa mediates factor IXa binding to platelets and assembly of the factor X activating complex.
Wong MY; Gurr JA; Walsh PN
Biochemistry; 1999 Jul; 38(28):8948-60. PubMed ID: 10413468
[TBL] [Abstract][Full Text] [Related]
5. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
[TBL] [Abstract][Full Text] [Related]
6. Nitrophorin-2: a novel mixed-type reversible specific inhibitor of the intrinsic factor-X activating complex.
Zhang Y; Ribeiro JM; Guimarães JA; Walsh PN
Biochemistry; 1998 Jul; 37(30):10681-90. PubMed ID: 9692958
[TBL] [Abstract][Full Text] [Related]
7. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
[TBL] [Abstract][Full Text] [Related]
8. Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.
Sheehan JP; Kobbervig CE; Kirkpatrick HM
Biochemistry; 2003 Sep; 42(38):11316-25. PubMed ID: 14503882
[TBL] [Abstract][Full Text] [Related]
9. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
[TBL] [Abstract][Full Text] [Related]
10. Factor VIIIa regulates substrate delivery to the intrinsic factor X-activating complex.
Panteleev MA; Ananyeva NM; Greco NJ; Ataullakhanov FI; Saenko EL
FEBS J; 2006 Jan; 273(2):374-87. PubMed ID: 16403024
[TBL] [Abstract][Full Text] [Related]
11. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
Ahmad SS; Walsh PN
Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
[TBL] [Abstract][Full Text] [Related]
12. Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
Takeyama M; Nogami K; Saenko EL; Soeda T; Nishiya K; Ogiwara K; Yoshioka A; Shima M
Br J Haematol; 2008 Nov; 143(3):409-20. PubMed ID: 18759761
[TBL] [Abstract][Full Text] [Related]
13. Factor X bound to the surface of activated human platelets is preferentially activated by platelet-bound factor IXa.
Scandura JM; Walsh PN
Biochemistry; 1996 Jul; 35(27):8903-13. PubMed ID: 8688426
[TBL] [Abstract][Full Text] [Related]
14. Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.
Jenkins PV; Dill JL; Zhou Q; Fay PJ
Biochemistry; 2004 May; 43(17):5094-101. PubMed ID: 15109268
[TBL] [Abstract][Full Text] [Related]
15. Identification of residues Asn89, Ile90, and Val107 of the factor IXa second epidermal growth factor domain that are essential for the assembly of the factor X-activating complex on activated platelets.
Yang X; Chang YJ; Lin SW; Walsh PN
J Biol Chem; 2004 Nov; 279(45):46400-5. PubMed ID: 15328360
[TBL] [Abstract][Full Text] [Related]
16. Binding studies of the enzyme (factor IXa) with the cofactor (factor VIIIa) in the assembly of factor-X activating complex on the activated platelet surface.
Ahmad SS; London FS; Walsh PN
J Thromb Haemost; 2003 Nov; 1(11):2348-55. PubMed ID: 14629468
[TBL] [Abstract][Full Text] [Related]
17. Partial activation of the factor VIIIa-factor IXa enzyme complex by dihexanoic phosphatidylserine at submicellar concentrations.
Gilbert GE; Arena AA
Biochemistry; 1997 Sep; 36(35):10768-76. PubMed ID: 9271508
[TBL] [Abstract][Full Text] [Related]
18. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII.
Gilbert GE; Arena AA
Biochemistry; 1998 Sep; 37(39):13526-35. PubMed ID: 9753438
[TBL] [Abstract][Full Text] [Related]
19. Factor IXa inhibition by protease nexin-2/amyloid beta-protein precursor on phospholipid vesicles and cell membranes.
Schmaier AH; Dahl LD; Hasan AA; Cines DB; Bauer KA; Van Nostrand WE
Biochemistry; 1995 Jan; 34(4):1171-8. PubMed ID: 7827067
[TBL] [Abstract][Full Text] [Related]
20. The factor IXa second epidermal growth factor (EGF2) domain mediates platelet binding and assembly of the factor X activating complex.
Wilkinson FH; Ahmad SS; Walsh PN
J Biol Chem; 2002 Feb; 277(8):5734-41. PubMed ID: 11714704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
